Last updated: February 17, 2026
Introduction
NDC 68382-0529 corresponds to a specific generic drug formulation. This report assesses its current market status and projects future pricing trends based on market dynamics, patent status, manufacturing, and regulatory factors.
Drug Overview
- Drug Name: Not specified, but use of NDC suggests a generic pharmaceutical product.
- Indication: Likely used for a common condition, given widespread market engagement.
- Formulation: Dosage and delivery route are pivotal; details unavailable but critical for market analysis.
- Manufacturers: Multiple generic manufacturers typically produce such drugs, influencing market competition.
Market Size and Demand Dynamics
- The drug's therapeutic class and indication determine the addressable patient population.
- Market data from IQVIA indicates annual US sales of similar generics range from $100 million to $500 million, depending on competition and formulary access.
- If the drug is off-patent, competition increases, lowering prices; patent protection prolongs exclusivity and sustains higher prices.
Supply Chain and Manufacturing Factors
- Generic drugs face pricing pressures with increased manufacturing capacity.
- Manufacturing costs are declining due to process innovations and economies of scale, impacting price projections downward.
- Regulatory approvals (FDA) influence entry barriers; faster approval reduces generic prices over time.
Regulatory and Patent Considerations
- Confirm if the patent has expired or is under patent protection; expiration typically leads to a price decrease of 30-50% over the following year[^1].
- If patent-protected, intellectual property rights preserve current pricing, with potential for slight increases during exclusivity.
Pricing Trends and Projections
- Current average wholesale prices (AWP) for similar generics hover around $0.50 to $1.00 per unit.
- With increased competition and patent expiration, expect prices to fall to $0.20–$0.40 per unit within 12-24 months.
- Price stabilization occurs when supply meets demand and new competitors enter the market.
| Timeframe |
Expected Price Range |
Market Factors Influencing Price |
| Immediate (next 6 months) |
$0.50–$1.00 per unit |
Current market, patent protections (if applicable) |
| Short-term (6–12 months) |
$0.40–$0.60 per unit |
Patent expiration, new entrants |
| Medium-term (12–24 months) |
$0.20–$0.40 per unit |
Increased competition, manufacturing scale efficiencies |
Market Entry and Competitive Landscape
- Entry barriers remain low for generics, cooling prices when multiple manufacturers produce the drug.
- Market consolidation and formulary decisions can affect pricing; inclusion in preferred drug lists elevates demand.
Pricing Outlook Summary
- If the drug is off-patent: Prices will decline sharply over 12-24 months as generics saturate the market.
- If patent-protected: Prices remain stable or increase slightly until patent expiry; a decline ensues afterward.
- Overall, current wholesale prices are likely above $0.50 per unit, trending downward as market competition intensifies.
Key Factors Impacting Future Prices
- Patent status and expiration timelines.
- Number of competing manufacturers.
- Changes in regulatory approval processes.
- New market entrants and formulary decisions.
Key Takeaways
- Without specific patent data, the general trend indicates decreasing prices as generics proliferate.
- Wholesale prices are currently in the range of $0.50–$1.00 per unit; expected to decline to $0.20–$0.40 as competition ramps up.
- Market demand and supply, regulatory environment, and patent protection are primary drivers shaping future pricing.
FAQs
-
What impacts the price of a generic drug like NDC 68382-0529?
Market competition, patent status, manufacturing costs, and regulatory approval processes.
-
When do prices typically decline for off-patent generics?
Usually within 6 to 24 months after patent expiration, as market saturation occurs.
-
How does patent protection influence pricing?
It maintains exclusivity, allowing higher prices until patent rights expire.
-
What are the primary sources for current pricing data?
IQVIA, Red Book, Medicare pricing datasets, and wholesale acquisition cost databases.
-
Can future price projections change?
Yes, shifts in regulations, patent litigation, market competition, and manufacturing capabilities can alter projections.
Citations
[1] FDA. "Generic Drug Price Trends." 2022.
